HEADER TRANSFERASE 29-AUG-02 1IYL TITLE CRYSTAL STRUCTURE OF CANDIDA ALBICANS N-MYRISTOYLTRANSFERASE WITH NON- TITLE 2 PEPTIDIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; COMPND 5 EC: 2.3.1.97; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_TAXID: 5476; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PKF19 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SOGABE,T.A.FUKAMI,K.MORIKAMI,Y.SHIRATORI,Y.AOKI,A.D'ARCY, AUTHOR 2 F.K.WINKLER,D.W.BANNER,T.OHTSUKA REVDAT 4 25-OCT-23 1IYL 1 REMARK REVDAT 3 13-JUL-11 1IYL 1 VERSN REVDAT 2 24-FEB-09 1IYL 1 VERSN REVDAT 1 30-DEC-02 1IYL 0 JRNL AUTH S.SOGABE,M.MASUBUCHI,K.SAKATA,T.A.FUKAMI,K.MORIKAMI, JRNL AUTH 2 Y.SHIRATORI,H.EBIIKE,K.KAWASAKI,Y.AOKI,N.SHIMMA,A.D'ARCY, JRNL AUTH 3 F.K.WINKLER,D.W.BANNER,T.OHTSUKA JRNL TITL CRYSTAL STRUCTURES OF CANDIDA ALBICANS JRNL TITL 2 N-MYRISTOYLTRANSFERASE WITH TWO DISTINCT INHIBITORS JRNL REF CHEM.BIOL. V. 9 1119 2002 JRNL REFN ISSN 1074-5521 JRNL PMID 12401496 JRNL DOI 10.1016/S1074-5521(02)00240-5 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 40638 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.288 REMARK 3 R VALUE (WORKING SET) : 0.284 REMARK 3 FREE R VALUE : 0.366 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2050 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 40638 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3751 REMARK 3 BIN R VALUE (WORKING SET) : 0.3270 REMARK 3 BIN FREE R VALUE : 0.4180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 201 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 12507 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.65 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.55 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.440 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : B-GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.420 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.410 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.230 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.23 REMARK 3 BSOL : 53.45 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IYL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-SEP-02. REMARK 100 THE DEPOSITION ID IS D_1000005411. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 288 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : WEISSENBERG REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40711 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.36400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1IYK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, LITHIUM SULFATE, HEPES, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 46.63850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 134.63850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.44250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 134.63850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.63850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.44250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 60 REMARK 465 GLY A 61 REMARK 465 PRO A 62 REMARK 465 ILE A 63 REMARK 465 ASP A 64 REMARK 465 LYS A 65 REMARK 465 LEU A 66 REMARK 465 LYS A 67 REMARK 465 GLU B 60 REMARK 465 GLY B 61 REMARK 465 PRO B 62 REMARK 465 ILE B 63 REMARK 465 ASP B 64 REMARK 465 LYS B 65 REMARK 465 LEU B 66 REMARK 465 LYS B 67 REMARK 465 THR B 68 REMARK 465 PRO B 69 REMARK 465 GLU B 70 REMARK 465 ASP B 71 REMARK 465 GLU C 60 REMARK 465 GLY C 61 REMARK 465 PRO C 62 REMARK 465 ILE C 63 REMARK 465 ASP C 64 REMARK 465 LYS C 65 REMARK 465 LEU C 66 REMARK 465 LYS C 67 REMARK 465 THR C 68 REMARK 465 PRO C 69 REMARK 465 GLU C 70 REMARK 465 GLU D 60 REMARK 465 GLY D 61 REMARK 465 PRO D 62 REMARK 465 ILE D 63 REMARK 465 ASP D 64 REMARK 465 LYS D 65 REMARK 465 LEU D 66 REMARK 465 LYS D 67 REMARK 465 THR D 68 REMARK 465 PRO D 69 REMARK 465 GLU D 70 REMARK 465 ASP D 71 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 107 C VAL A 108 N -0.363 REMARK 500 ALA B 113 C THR B 114 N -0.179 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA A 113 O - C - N ANGL. DEV. = -15.2 DEGREES REMARK 500 THR A 114 C - N - CA ANGL. DEV. = 21.6 DEGREES REMARK 500 TYR C 107 CA - C - N ANGL. DEV. = -14.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 90 6.30 -67.88 REMARK 500 VAL A 108 -166.66 -48.75 REMARK 500 GLU A 109 -149.96 168.25 REMARK 500 ALA A 113 94.95 85.14 REMARK 500 THR A 114 3.76 163.96 REMARK 500 LYS A 118 72.54 -103.52 REMARK 500 ASP A 136 -7.86 -56.77 REMARK 500 SER A 145 -71.56 -50.72 REMARK 500 ASN A 166 79.58 54.15 REMARK 500 SER A 171 -158.21 -139.33 REMARK 500 LYS A 181 -32.37 -39.62 REMARK 500 LYS A 182 45.66 -109.75 REMARK 500 LEU A 183 18.08 -151.50 REMARK 500 ASN A 185 35.61 74.81 REMARK 500 SER A 214 27.43 -64.98 REMARK 500 ILE A 215 -80.83 -65.08 REMARK 500 ASN A 246 101.44 39.52 REMARK 500 GLN A 247 -134.81 -157.94 REMARK 500 THR A 248 121.04 -175.70 REMARK 500 PRO A 259 177.84 -54.18 REMARK 500 THR A 277 -70.30 -56.89 REMARK 500 HIS A 307 -46.34 -25.65 REMARK 500 ASN A 310 5.60 -60.66 REMARK 500 LEU A 337 89.49 -160.44 REMARK 500 LEU A 342 -107.75 -68.95 REMARK 500 ASP A 343 60.57 -61.38 REMARK 500 GLN A 346 -61.29 -106.20 REMARK 500 GLU A 349 116.59 -162.93 REMARK 500 PHE A 356 -121.08 -99.21 REMARK 500 LYS A 365 170.02 -59.04 REMARK 500 TYR A 368 -82.58 -31.15 REMARK 500 LEU A 394 -162.62 -102.60 REMARK 500 GLN A 397 -147.87 55.78 REMARK 500 ASP A 398 42.71 -105.60 REMARK 500 LEU A 403 -79.86 -52.57 REMARK 500 LYS A 407 29.75 81.11 REMARK 500 ASN A 421 65.66 62.85 REMARK 500 TYR A 422 114.44 175.24 REMARK 500 THR A 424 140.83 -172.38 REMARK 500 LYS A 436 18.04 54.59 REMARK 500 GLU A 440 164.04 -45.20 REMARK 500 ASP A 441 77.80 15.93 REMARK 500 ASP B 75 117.79 60.56 REMARK 500 ASN B 106 -34.72 -131.56 REMARK 500 TYR B 107 103.68 -46.52 REMARK 500 VAL B 108 90.14 -1.09 REMARK 500 GLU B 109 155.45 -46.76 REMARK 500 ASP B 110 -81.03 -63.04 REMARK 500 ILE B 111 -0.99 177.22 REMARK 500 ALA B 113 64.55 32.07 REMARK 500 REMARK 500 THIS ENTRY HAS 247 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 TYR C 107 -12.85 REMARK 500 TYR D 107 16.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R64 A 452 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R64 B 452 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R64 C 452 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IYK RELATED DB: PDB REMARK 900 1IYK CONTAINS THE SAME PROTEIN COMPLEXED WITH PEPTIDIC INHIBITOR. DBREF 1IYL A 60 451 UNP P30418 NMT_CANAL 60 451 DBREF 1IYL B 60 451 UNP P30418 NMT_CANAL 60 451 DBREF 1IYL C 60 451 UNP P30418 NMT_CANAL 60 451 DBREF 1IYL D 60 451 UNP P30418 NMT_CANAL 60 451 SEQRES 1 A 392 GLU GLY PRO ILE ASP LYS LEU LYS THR PRO GLU ASP VAL SEQRES 2 A 392 PRO ASN ASP PRO LEU PRO LEU ILE SER ASP PHE GLU TRP SEQRES 3 A 392 SER THR LEU ASP ILE ASP ASP ASN LEU GLN LEU ASP GLU SEQRES 4 A 392 LEU TYR LYS LEU LEU TYR ASP ASN TYR VAL GLU ASP ILE SEQRES 5 A 392 ASP ALA THR PHE ARG PHE LYS TYR SER HIS GLU PHE PHE SEQRES 6 A 392 GLN TRP ALA LEU LYS PRO PRO GLY TRP ARG LYS ASP TRP SEQRES 7 A 392 HIS VAL GLY VAL ARG VAL LYS SER THR GLY LYS LEU VAL SEQRES 8 A 392 ALA PHE ILE ALA ALA THR PRO VAL THR PHE LYS LEU ASN SEQRES 9 A 392 LYS SER ASN LYS VAL ILE ASP SER VAL GLU ILE ASN PHE SEQRES 10 A 392 LEU CYS ILE HIS LYS LYS LEU ARG ASN LYS ARG LEU ALA SEQRES 11 A 392 PRO VAL LEU ILE LYS GLU ILE THR ARG ARG VAL ASN LYS SEQRES 12 A 392 GLN ASN ILE TRP GLN ALA LEU TYR THR GLY GLY SER ILE SEQRES 13 A 392 LEU PRO THR PRO LEU THR THR CYS ARG TYR GLN HIS ARG SEQRES 14 A 392 PRO ILE ASN TRP SER LYS LEU HIS ASP VAL GLY PHE SER SEQRES 15 A 392 HIS LEU PRO PRO ASN GLN THR LYS SER SER MET VAL ALA SEQRES 16 A 392 SER TYR THR LEU PRO ASN ASN PRO LYS LEU LYS GLY LEU SEQRES 17 A 392 ARG PRO MET THR GLY LYS ASP VAL SER THR VAL LEU SER SEQRES 18 A 392 LEU LEU TYR LYS TYR GLN GLU ARG PHE ASP ILE VAL GLN SEQRES 19 A 392 LEU PHE THR GLU GLU GLU PHE LYS HIS TRP MET LEU GLY SEQRES 20 A 392 HIS ASP GLU ASN SER ASP SER ASN VAL VAL LYS SER TYR SEQRES 21 A 392 VAL VAL GLU ASP GLU ASN GLY ILE ILE THR ASP TYR PHE SEQRES 22 A 392 SER TYR TYR LEU LEU PRO PHE THR VAL LEU ASP ASN ALA SEQRES 23 A 392 GLN HIS ASP GLU LEU GLY ILE ALA TYR LEU PHE TYR TYR SEQRES 24 A 392 ALA SER ASP SER PHE GLU LYS PRO ASN TYR LYS LYS ARG SEQRES 25 A 392 LEU ASN GLU LEU ILE THR ASP ALA LEU ILE THR SER LYS SEQRES 26 A 392 LYS PHE GLY VAL ASP VAL PHE ASN CYS LEU THR CYS GLN SEQRES 27 A 392 ASP ASN THR TYR PHE LEU LYS ASP CYS LYS PHE GLY SER SEQRES 28 A 392 GLY ASP GLY PHE LEU ASN TYR TYR LEU PHE ASN TYR ARG SEQRES 29 A 392 THR PHE PRO MET ASP GLY GLY ILE ASP LYS LYS THR LYS SEQRES 30 A 392 GLU VAL VAL GLU ASP GLN THR SER GLY ILE GLY VAL VAL SEQRES 31 A 392 LEU LEU SEQRES 1 B 392 GLU GLY PRO ILE ASP LYS LEU LYS THR PRO GLU ASP VAL SEQRES 2 B 392 PRO ASN ASP PRO LEU PRO LEU ILE SER ASP PHE GLU TRP SEQRES 3 B 392 SER THR LEU ASP ILE ASP ASP ASN LEU GLN LEU ASP GLU SEQRES 4 B 392 LEU TYR LYS LEU LEU TYR ASP ASN TYR VAL GLU ASP ILE SEQRES 5 B 392 ASP ALA THR PHE ARG PHE LYS TYR SER HIS GLU PHE PHE SEQRES 6 B 392 GLN TRP ALA LEU LYS PRO PRO GLY TRP ARG LYS ASP TRP SEQRES 7 B 392 HIS VAL GLY VAL ARG VAL LYS SER THR GLY LYS LEU VAL SEQRES 8 B 392 ALA PHE ILE ALA ALA THR PRO VAL THR PHE LYS LEU ASN SEQRES 9 B 392 LYS SER ASN LYS VAL ILE ASP SER VAL GLU ILE ASN PHE SEQRES 10 B 392 LEU CYS ILE HIS LYS LYS LEU ARG ASN LYS ARG LEU ALA SEQRES 11 B 392 PRO VAL LEU ILE LYS GLU ILE THR ARG ARG VAL ASN LYS SEQRES 12 B 392 GLN ASN ILE TRP GLN ALA LEU TYR THR GLY GLY SER ILE SEQRES 13 B 392 LEU PRO THR PRO LEU THR THR CYS ARG TYR GLN HIS ARG SEQRES 14 B 392 PRO ILE ASN TRP SER LYS LEU HIS ASP VAL GLY PHE SER SEQRES 15 B 392 HIS LEU PRO PRO ASN GLN THR LYS SER SER MET VAL ALA SEQRES 16 B 392 SER TYR THR LEU PRO ASN ASN PRO LYS LEU LYS GLY LEU SEQRES 17 B 392 ARG PRO MET THR GLY LYS ASP VAL SER THR VAL LEU SER SEQRES 18 B 392 LEU LEU TYR LYS TYR GLN GLU ARG PHE ASP ILE VAL GLN SEQRES 19 B 392 LEU PHE THR GLU GLU GLU PHE LYS HIS TRP MET LEU GLY SEQRES 20 B 392 HIS ASP GLU ASN SER ASP SER ASN VAL VAL LYS SER TYR SEQRES 21 B 392 VAL VAL GLU ASP GLU ASN GLY ILE ILE THR ASP TYR PHE SEQRES 22 B 392 SER TYR TYR LEU LEU PRO PHE THR VAL LEU ASP ASN ALA SEQRES 23 B 392 GLN HIS ASP GLU LEU GLY ILE ALA TYR LEU PHE TYR TYR SEQRES 24 B 392 ALA SER ASP SER PHE GLU LYS PRO ASN TYR LYS LYS ARG SEQRES 25 B 392 LEU ASN GLU LEU ILE THR ASP ALA LEU ILE THR SER LYS SEQRES 26 B 392 LYS PHE GLY VAL ASP VAL PHE ASN CYS LEU THR CYS GLN SEQRES 27 B 392 ASP ASN THR TYR PHE LEU LYS ASP CYS LYS PHE GLY SER SEQRES 28 B 392 GLY ASP GLY PHE LEU ASN TYR TYR LEU PHE ASN TYR ARG SEQRES 29 B 392 THR PHE PRO MET ASP GLY GLY ILE ASP LYS LYS THR LYS SEQRES 30 B 392 GLU VAL VAL GLU ASP GLN THR SER GLY ILE GLY VAL VAL SEQRES 31 B 392 LEU LEU SEQRES 1 C 392 GLU GLY PRO ILE ASP LYS LEU LYS THR PRO GLU ASP VAL SEQRES 2 C 392 PRO ASN ASP PRO LEU PRO LEU ILE SER ASP PHE GLU TRP SEQRES 3 C 392 SER THR LEU ASP ILE ASP ASP ASN LEU GLN LEU ASP GLU SEQRES 4 C 392 LEU TYR LYS LEU LEU TYR ASP ASN TYR VAL GLU ASP ILE SEQRES 5 C 392 ASP ALA THR PHE ARG PHE LYS TYR SER HIS GLU PHE PHE SEQRES 6 C 392 GLN TRP ALA LEU LYS PRO PRO GLY TRP ARG LYS ASP TRP SEQRES 7 C 392 HIS VAL GLY VAL ARG VAL LYS SER THR GLY LYS LEU VAL SEQRES 8 C 392 ALA PHE ILE ALA ALA THR PRO VAL THR PHE LYS LEU ASN SEQRES 9 C 392 LYS SER ASN LYS VAL ILE ASP SER VAL GLU ILE ASN PHE SEQRES 10 C 392 LEU CYS ILE HIS LYS LYS LEU ARG ASN LYS ARG LEU ALA SEQRES 11 C 392 PRO VAL LEU ILE LYS GLU ILE THR ARG ARG VAL ASN LYS SEQRES 12 C 392 GLN ASN ILE TRP GLN ALA LEU TYR THR GLY GLY SER ILE SEQRES 13 C 392 LEU PRO THR PRO LEU THR THR CYS ARG TYR GLN HIS ARG SEQRES 14 C 392 PRO ILE ASN TRP SER LYS LEU HIS ASP VAL GLY PHE SER SEQRES 15 C 392 HIS LEU PRO PRO ASN GLN THR LYS SER SER MET VAL ALA SEQRES 16 C 392 SER TYR THR LEU PRO ASN ASN PRO LYS LEU LYS GLY LEU SEQRES 17 C 392 ARG PRO MET THR GLY LYS ASP VAL SER THR VAL LEU SER SEQRES 18 C 392 LEU LEU TYR LYS TYR GLN GLU ARG PHE ASP ILE VAL GLN SEQRES 19 C 392 LEU PHE THR GLU GLU GLU PHE LYS HIS TRP MET LEU GLY SEQRES 20 C 392 HIS ASP GLU ASN SER ASP SER ASN VAL VAL LYS SER TYR SEQRES 21 C 392 VAL VAL GLU ASP GLU ASN GLY ILE ILE THR ASP TYR PHE SEQRES 22 C 392 SER TYR TYR LEU LEU PRO PHE THR VAL LEU ASP ASN ALA SEQRES 23 C 392 GLN HIS ASP GLU LEU GLY ILE ALA TYR LEU PHE TYR TYR SEQRES 24 C 392 ALA SER ASP SER PHE GLU LYS PRO ASN TYR LYS LYS ARG SEQRES 25 C 392 LEU ASN GLU LEU ILE THR ASP ALA LEU ILE THR SER LYS SEQRES 26 C 392 LYS PHE GLY VAL ASP VAL PHE ASN CYS LEU THR CYS GLN SEQRES 27 C 392 ASP ASN THR TYR PHE LEU LYS ASP CYS LYS PHE GLY SER SEQRES 28 C 392 GLY ASP GLY PHE LEU ASN TYR TYR LEU PHE ASN TYR ARG SEQRES 29 C 392 THR PHE PRO MET ASP GLY GLY ILE ASP LYS LYS THR LYS SEQRES 30 C 392 GLU VAL VAL GLU ASP GLN THR SER GLY ILE GLY VAL VAL SEQRES 31 C 392 LEU LEU SEQRES 1 D 392 GLU GLY PRO ILE ASP LYS LEU LYS THR PRO GLU ASP VAL SEQRES 2 D 392 PRO ASN ASP PRO LEU PRO LEU ILE SER ASP PHE GLU TRP SEQRES 3 D 392 SER THR LEU ASP ILE ASP ASP ASN LEU GLN LEU ASP GLU SEQRES 4 D 392 LEU TYR LYS LEU LEU TYR ASP ASN TYR VAL GLU ASP ILE SEQRES 5 D 392 ASP ALA THR PHE ARG PHE LYS TYR SER HIS GLU PHE PHE SEQRES 6 D 392 GLN TRP ALA LEU LYS PRO PRO GLY TRP ARG LYS ASP TRP SEQRES 7 D 392 HIS VAL GLY VAL ARG VAL LYS SER THR GLY LYS LEU VAL SEQRES 8 D 392 ALA PHE ILE ALA ALA THR PRO VAL THR PHE LYS LEU ASN SEQRES 9 D 392 LYS SER ASN LYS VAL ILE ASP SER VAL GLU ILE ASN PHE SEQRES 10 D 392 LEU CYS ILE HIS LYS LYS LEU ARG ASN LYS ARG LEU ALA SEQRES 11 D 392 PRO VAL LEU ILE LYS GLU ILE THR ARG ARG VAL ASN LYS SEQRES 12 D 392 GLN ASN ILE TRP GLN ALA LEU TYR THR GLY GLY SER ILE SEQRES 13 D 392 LEU PRO THR PRO LEU THR THR CYS ARG TYR GLN HIS ARG SEQRES 14 D 392 PRO ILE ASN TRP SER LYS LEU HIS ASP VAL GLY PHE SER SEQRES 15 D 392 HIS LEU PRO PRO ASN GLN THR LYS SER SER MET VAL ALA SEQRES 16 D 392 SER TYR THR LEU PRO ASN ASN PRO LYS LEU LYS GLY LEU SEQRES 17 D 392 ARG PRO MET THR GLY LYS ASP VAL SER THR VAL LEU SER SEQRES 18 D 392 LEU LEU TYR LYS TYR GLN GLU ARG PHE ASP ILE VAL GLN SEQRES 19 D 392 LEU PHE THR GLU GLU GLU PHE LYS HIS TRP MET LEU GLY SEQRES 20 D 392 HIS ASP GLU ASN SER ASP SER ASN VAL VAL LYS SER TYR SEQRES 21 D 392 VAL VAL GLU ASP GLU ASN GLY ILE ILE THR ASP TYR PHE SEQRES 22 D 392 SER TYR TYR LEU LEU PRO PHE THR VAL LEU ASP ASN ALA SEQRES 23 D 392 GLN HIS ASP GLU LEU GLY ILE ALA TYR LEU PHE TYR TYR SEQRES 24 D 392 ALA SER ASP SER PHE GLU LYS PRO ASN TYR LYS LYS ARG SEQRES 25 D 392 LEU ASN GLU LEU ILE THR ASP ALA LEU ILE THR SER LYS SEQRES 26 D 392 LYS PHE GLY VAL ASP VAL PHE ASN CYS LEU THR CYS GLN SEQRES 27 D 392 ASP ASN THR TYR PHE LEU LYS ASP CYS LYS PHE GLY SER SEQRES 28 D 392 GLY ASP GLY PHE LEU ASN TYR TYR LEU PHE ASN TYR ARG SEQRES 29 D 392 THR PHE PRO MET ASP GLY GLY ILE ASP LYS LYS THR LYS SEQRES 30 D 392 GLU VAL VAL GLU ASP GLN THR SER GLY ILE GLY VAL VAL SEQRES 31 D 392 LEU LEU HET R64 A 452 30 HET R64 B 452 30 HET R64 C 452 30 HETNAM R64 (1-METHYL-1H-IMIDAZOL-2-YL)-(3-METHYL-4-{3-[(PYRIDIN-3- HETNAM 2 R64 YLMETHYL)-AMINO]-PROPOXY}-BENZOFURAN-2-YL)-METHANONE FORMUL 5 R64 3(C23 H24 N4 O3) HELIX 1 1 ASP A 92 TYR A 107 1 16 HELIX 2 2 SER A 120 LYS A 129 1 10 HELIX 3 3 ARG A 134 ASP A 136 5 3 HELIX 4 4 ARG A 187 LYS A 202 1 16 HELIX 5 5 ASN A 231 VAL A 238 1 8 HELIX 6 6 THR A 248 TYR A 256 1 9 HELIX 7 7 ASP A 274 GLN A 286 1 13 HELIX 8 8 GLU A 287 PHE A 289 5 3 HELIX 9 9 THR A 296 GLY A 306 1 11 HELIX 10 10 ASN A 367 LYS A 384 1 18 HELIX 11 11 LYS A 385 GLY A 387 5 3 HELIX 12 12 ASP A 398 PHE A 402 5 5 HELIX 13 13 LEU A 403 LYS A 407 5 5 HELIX 14 14 ASP B 92 TYR B 107 1 16 HELIX 15 15 GLU B 122 LYS B 129 1 8 HELIX 16 16 ARG B 134 ASP B 136 5 3 HELIX 17 17 LYS B 164 ASN B 166 5 3 HELIX 18 18 LYS B 181 ARG B 184 5 4 HELIX 19 19 LEU B 188 LYS B 202 1 15 HELIX 20 20 ASN B 231 VAL B 238 1 8 HELIX 21 21 THR B 248 THR B 257 1 10 HELIX 22 22 VAL B 275 GLU B 287 1 13 HELIX 23 23 THR B 296 GLY B 306 1 11 HELIX 24 24 SER B 362 GLU B 364 5 3 HELIX 25 25 ASN B 367 LYS B 385 1 19 HELIX 26 26 ASP B 398 TYR B 401 5 4 HELIX 27 27 PHE B 402 LYS B 407 1 6 HELIX 28 28 ASP C 92 TYR C 107 1 16 HELIX 29 29 SER C 120 LYS C 129 1 10 HELIX 30 30 ARG C 134 ASP C 136 5 3 HELIX 31 31 LEU C 188 LYS C 202 1 15 HELIX 32 32 ASN C 231 VAL C 238 1 8 HELIX 33 33 THR C 248 TYR C 256 1 9 HELIX 34 34 ASP C 274 GLU C 287 1 14 HELIX 35 35 THR C 296 GLY C 306 1 11 HELIX 36 36 ASN C 367 LYS C 384 1 18 HELIX 37 37 LYS C 385 GLY C 387 5 3 HELIX 38 38 ASP C 398 PHE C 402 5 5 HELIX 39 39 ASP D 92 TYR D 107 1 16 HELIX 40 40 HIS D 121 ALA D 127 1 7 HELIX 41 41 ARG D 134 ASP D 136 5 3 HELIX 42 42 LYS D 181 ARG D 184 5 4 HELIX 43 43 ARG D 187 LYS D 202 1 16 HELIX 44 44 ASN D 231 HIS D 236 1 6 HELIX 45 45 ASP D 237 GLY D 239 5 3 HELIX 46 46 MET D 252 THR D 257 1 6 HELIX 47 47 LYS D 273 GLU D 287 1 15 HELIX 48 48 THR D 296 LEU D 305 1 10 HELIX 49 49 ASN D 367 THR D 382 1 16 HELIX 50 50 ASN D 399 LYS D 404 1 6 SHEET 1 A14 PHE A 83 THR A 87 0 SHEET 2 A14 HIS A 138 VAL A 143 -1 O GLY A 140 N SER A 86 SHEET 3 A14 LEU A 149 LEU A 162 -1 N VAL A 150 O VAL A 141 SHEET 4 A14 ILE A 291 GLN A 293 -1 N VAL A 292 O LYS A 161 SHEET 5 A14 LEU A 149 LEU A 162 -1 O LYS A 161 N VAL A 292 SHEET 6 A14 LYS A 167 ILE A 179 -1 O LYS A 167 N LEU A 162 SHEET 7 A14 ALA A 208 GLY A 212 1 O LEU A 209 N ILE A 174 SHEET 8 A14 GLY A 409 PHE A 420 -1 O ASN A 416 N GLY A 212 SHEET 9 A14 THR A 222 PRO A 229 -1 O CYS A 223 N LEU A 415 SHEET 10 A14 VAL A 390 CYS A 393 -1 O PHE A 391 N ARG A 228 SHEET 11 A14 ILE A 352 SER A 360 1 O ALA A 353 N ASN A 392 SHEET 12 A14 ILE A 328 LEU A 336 -1 O TYR A 331 N ALA A 359 SHEET 13 A14 VAL A 316 GLU A 322 -1 N LYS A 317 O TYR A 334 SHEET 14 A14 LEU A 267 PRO A 269 -1 O ARG A 268 N VAL A 320 SHEET 1 B 2 PHE A 115 PHE A 117 0 SHEET 2 B 2 PHE A 339 VAL A 341 -1 N THR A 340 O ARG A 116 SHEET 1 C 8 PHE B 83 THR B 87 0 SHEET 2 C 8 HIS B 138 VAL B 143 -1 O GLY B 140 N SER B 86 SHEET 3 C 8 ALA B 151 LEU B 162 -1 O ALA B 151 N VAL B 141 SHEET 4 C 8 ILE B 291 GLN B 293 -1 O VAL B 292 N LYS B 161 SHEET 5 C 8 ALA B 151 LEU B 162 -1 N LYS B 161 O VAL B 292 SHEET 6 C 8 ASP B 170 ILE B 179 -1 O SER B 171 N VAL B 158 SHEET 7 C 8 ALA B 208 TYR B 210 1 N LEU B 209 O VAL B 172 SHEET 8 C 8 LEU B 419 PHE B 420 -1 N PHE B 420 O ALA B 208 SHEET 1 D 2 PHE B 115 PHE B 117 0 SHEET 2 D 2 PHE B 339 VAL B 341 -1 N THR B 340 O ARG B 116 SHEET 1 E 7 LEU B 267 PRO B 269 0 SHEET 2 E 7 VAL B 316 GLU B 322 -1 N VAL B 320 O ARG B 268 SHEET 3 E 7 ILE B 328 LEU B 336 -1 N THR B 329 O VAL B 321 SHEET 4 E 7 GLY B 351 SER B 360 -1 N TYR B 354 O TYR B 335 SHEET 5 E 7 VAL B 388 LEU B 394 1 N ASP B 389 O GLY B 351 SHEET 6 E 7 THR B 222 PRO B 229 -1 N GLN B 226 O CYS B 393 SHEET 7 E 7 GLY B 409 ASN B 416 -1 N GLY B 409 O HIS B 227 SHEET 1 F16 PHE C 83 TRP C 85 0 SHEET 2 F16 HIS C 138 VAL C 143 -1 N ARG C 142 O GLU C 84 SHEET 3 F16 LEU C 149 LEU C 162 -1 N VAL C 150 O VAL C 141 SHEET 4 F16 ILE C 291 LEU C 294 -1 O VAL C 292 N LYS C 161 SHEET 5 F16 LEU C 149 LEU C 162 -1 O THR C 159 N LEU C 294 SHEET 6 F16 LYS C 167 ILE C 179 -1 O LYS C 167 N LEU C 162 SHEET 7 F16 ALA C 208 GLY C 213 1 O LEU C 209 N ILE C 174 SHEET 8 F16 GLY C 409 PHE C 420 -1 O ASN C 416 N GLY C 212 SHEET 9 F16 THR C 221 PRO C 229 -1 N THR C 221 O TYR C 417 SHEET 10 F16 VAL C 390 LEU C 394 -1 N PHE C 391 O ARG C 228 SHEET 11 F16 ILE C 352 LEU C 355 1 O ALA C 353 N ASN C 392 SHEET 12 F16 ILE C 328 LEU C 336 -1 O TYR C 335 N TYR C 354 SHEET 13 F16 ALA C 359 SER C 360 -1 N ALA C 359 O TYR C 331 SHEET 14 F16 ILE C 328 LEU C 336 -1 O TYR C 331 N ALA C 359 SHEET 15 F16 VAL C 316 GLU C 322 -1 N LYS C 317 O TYR C 334 SHEET 16 F16 LEU C 267 PRO C 269 -1 O ARG C 268 N VAL C 320 SHEET 1 G 6 PHE D 83 THR D 87 0 SHEET 2 G 6 HIS D 138 VAL D 143 -1 N GLY D 140 O SER D 86 SHEET 3 G 6 LEU D 149 THR D 159 -1 N VAL D 150 O VAL D 141 SHEET 4 G 6 ASP D 170 ILE D 179 -1 N SER D 171 O VAL D 158 SHEET 5 G 6 GLN D 207 LEU D 209 1 O GLN D 207 N VAL D 172 SHEET 6 G 6 LEU D 419 PHE D 420 -1 O PHE D 420 N ALA D 208 SHEET 1 H 3 ARG D 116 PHE D 117 0 SHEET 2 H 3 PHE D 339 THR D 340 -1 O THR D 340 N ARG D 116 SHEET 3 H 3 GLU D 349 LEU D 350 -1 O LEU D 350 N PHE D 339 SHEET 1 I 3 GLN D 226 PRO D 229 0 SHEET 2 I 3 VAL D 390 CYS D 393 -1 O PHE D 391 N ARG D 228 SHEET 3 I 3 ALA D 353 TYR D 354 1 O ALA D 353 N ASN D 392 SHEET 1 J 2 LYS D 317 SER D 318 0 SHEET 2 J 2 SER D 333 TYR D 334 -1 O TYR D 334 N LYS D 317 CISPEP 1 THR A 68 PRO A 69 0 -0.20 SITE 1 AC1 12 TYR A 107 ASP A 110 TYR A 119 PHE A 176 SITE 2 AC1 12 TYR A 225 HIS A 227 PHE A 240 PHE A 339 SITE 3 AC1 12 ASN A 392 CYS A 393 LEU A 394 LEU A 451 SITE 1 AC2 13 TYR B 107 PHE B 117 TYR B 119 ASN B 175 SITE 2 AC2 13 PHE B 176 TYR B 225 HIS B 227 PHE B 240 SITE 3 AC2 13 PHE B 339 ILE B 352 ASN B 392 CYS B 393 SITE 4 AC2 13 LEU B 451 SITE 1 AC3 13 TYR C 107 ILE C 111 PHE C 117 TYR C 119 SITE 2 AC3 13 ASN C 175 PHE C 176 TYR C 225 HIS C 227 SITE 3 AC3 13 PHE C 240 PHE C 339 ASN C 392 LEU C 394 SITE 4 AC3 13 LEU C 451 CRYST1 93.277 96.885 269.277 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010721 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010322 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003714 0.00000